CCGTX | RCKTX | CCGTX / RCKTX | |
Total Expense Ratio | 1.42 | 1.00 | 142% |
Annual Report Gross Expense Ratio | 1.42 | 1.00 | 142% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 9.383 | 9.673 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 47.7B | 47.7B | 100% |
Annual Yield % from dividends | 0.51 | 0.88 | 57% |
Returns for 1 year | 11.49 | 12.00 | 96% |
Returns for 3 years | 30.61 | 31.90 | 96% |
Returns for 5 years | 36.21 | 38.47 | 94% |
Returns for 10 years | 66.82 | 71.11 | 94% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 26.17 | 0.40 | +1.57% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PSL | 108.30 | 0.08 | +0.07% |
Invesco DW Consumer Staples Momt ETF | |||
BGJTF | 9.92 | N/A | N/A |
Baillie Gifford Japan Trust Plc. (The) | |||
ESML | 41.34 | -0.68 | -1.62% |
iShares ESG Aware MSCI USA Small-Cap ETF | |||
GVIP | 138.60 | -2.40 | -1.70% |
Goldman Sachs Hedge Industry VIP ETF |